observed high levels of VWF and coagulation factor VIII that released from injured endothelial cells could contribute to hypercoagulability and the elevated rate of venous thromboembolism (VTE) in COVID-19 patients, suggesting that VWF could be used for the hierarchy of endothelial damage and thrombotic risk (172). This evidence concerns the gene VWF and thrombophilia.